Circulating tumour cell dynamics as a predictor for treatment response and prognosis in metastatic breast cancer patients
Circulating tumour cell dynamics as a predictor for treatment response and prognosis in metastatic breast cancer patients
ETNK1 mutations in atypical chronic myeloid leukaemia can be reverted with phosphoethanolamine
Latest data for managing ALK NSCLC patients
Pregnancy outcomes in breast cancer survivors; meta-analysis
ASCENT: A phase II trial of induction, consolidation and maintenance in subjects with high risk smouldering MM
Peripheral blood CD26 leukaemia stem cell monitoring in CML during TKI treatment
Decitabine plus ipilimumab in r/r MDS/AML in the post-BMT or transplant naïve settings
Treating acute leukaemias of ambiguous lineage
First-in-class STAMP inhibitor asciminib in patients with CML harbouring the T315I mutation
Weekly carfilzomib, lenalidomide, dexamethasone and daratumumab (wKRd-D) combination therapy in newly diagnosed multiple myeloma
Analysis of the B-HOLISTIC study and importance of relapsed/refractory Hodgkin lymphoma real world evidence data
Five year update of ECHELON-1 for classical Hodgkin lymphoma